av/morphosys--big.svg

SIX:MOR

MorphoSys AG

  • Stock

67.25

−0.66%

−0.45

USD last updated 27/07 01:51:33

Last Close

67.70

02/08 15:36

Market Cap

2.55B

Beta: 0.71

Volume Today

4.33K

Avg: -

PE Ratio

40.47

PFCF: −7.99

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -10-55102016-09-292018-09-292020-09-292022-09-292024-03-14

    Revenue (Estimate*)

    50M100M150M200M250M2016-09-292018-09-292020-09-292022-09-292024-03-14

    *Estimate based on analyst consensus